Last Posted: Oct 05, 2018
- Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study.
Mandelblatt Jeanne S et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 Oct JCO1800140 - Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria.
Hoyer Juliane et al. BMC cancer 2018 Sep 18(1) 926 - Cancer prevention: Molecular and epidemiologic consensus
M Song et al, Science, September 27, 2018 - Comprehensive Analysis of Germline Variants in Mexican Patients with Hereditary Breast and Ovarian Cancer Susceptibility.
Quezada Urban Rosalía et al. Cancers 2018 Sep 10(10) - Dealing With BRCA1/2 Unclassified Variants in a Cancer Genetics Clinic: Does Cosegregation Analysis Help?
Zuntini Roberta et al. Frontiers in genetics 2018 9378 - Development and pilot testing of a leaflet informing women with breast cancer about genomic testing for polygenic risk.
Kaur Rajneesh et al. Familial cancer 2018 Sep - Distribution and Clinical Utility of the 21-gene Recurrence Score in Pure Mucinous Breast Cancer Patients: a case-control study.
Wang Wei et al. Journal of Cancer 2018 9(18) 3216-3224 - Electronically ascertained extended pedigrees in breast cancer genetic counseling.
Stefansdottir V et al. Familial cancer 2018 Sep - Genetics of breast cancer in African populations: a literature review.
Abbad A et al. Global health, epidemiology and genomics 2018 3e8 - Precision medicine based on tumorigenic signaling pathways for triple-negative breast cancer.
Wu Nan et al. Oncology letters 2018 Oct 16(4) 4984-4996
.png)
No hay comentarios:
Publicar un comentario